NDC 73070-503
Insulin Degludec
Insulin Degludec
Insulin Degludec is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk Pharma, Inc.. The primary component is Insulin Degludec.
| Product ID | 73070-503_c1be283d-4b1d-4996-b2a7-4488dbff3037 |
| NDC | 73070-503 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Insulin Degludec |
| Generic Name | Insulin Degludec |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2022-07-01 |
| Marketing Category | BLA / |
| Application Number | BLA203314 |
| Labeler Name | Novo Nordisk Pharma, Inc. |
| Substance Name | INSULIN DEGLUDEC |
| Active Ingredient Strength | 200 U/mL |
| Pharm Classes | Insulin Analog [EPC], Insulin [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |